Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

Corflow Therapeutics AG

Neuhofstrasse 3d, 6340

About the sponsor

Corflow Therapeutics AG focuses on ST-elevated myocardial infarction and related acute coronary syndrome presentations, with attention to patients experiencing microvascular obstruction after coronary reperfusion.

  • STEMI
  • STEACS
  • Microvascular obstruction

The sponsor's clinical interest centers on cardiovascular injury linked to impaired microcirculation and the treatment of coronary complications following acute ischemic events.

About Specializations

Corflow Therapeutics AG runs clinical trials in conditions such as Acute myocardial infarction, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Acute myocardial infarction

Recruiting

A study of tirofiban and adenosine to treat small blood vessel damage in patients with ST-elevation myocardial infarction

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Adenosine
  • Sponsor:Corflow Therapeutics AG

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.